- Home
- CLDX vs LGIH Comparison
CLDX vs LGIH Comparison
Compare CLDX & LGIH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDX
- LGIH
- Stock Information
- Founded
- CLDX 1983
- LGIH 2003
- Country
- CLDX United States
- LGIH United States
- Employees
- CLDX N/A
- LGIH N/A
- Industry
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- LGIH Homebuilding
- Sector
- CLDX Health Care
- LGIH Consumer Discretionary
- Exchange
- CLDX Nasdaq
- LGIH Nasdaq
- Market Cap
- CLDX 1.8B
- LGIH 2.1B
- IPO Year
- CLDX 2008
- LGIH 2013
- Fundamental
- Price
- CLDX $25.14
- LGIH $89.20
- Analyst Decision
- CLDX Buy
- LGIH Hold
- Analyst Count
- CLDX 7
- LGIH 5
- Target Price
- CLDX $64.83
- LGIH $122.40
- AVG Volume (30 Days)
- CLDX 914.2K
- LGIH 205.9K
- Earning Date
- CLDX 02-24-2025
- LGIH 02-18-2025
- Dividend Yield
- CLDX N/A
- LGIH N/A
- EPS Growth
- CLDX N/A
- LGIH 9.16
- EPS
- CLDX N/A
- LGIH 8.36
- Revenue
- CLDX $9,976,000.00
- LGIH $2,253,616,000.00
- Revenue This Year
- CLDX N/A
- LGIH N/A
- Revenue Next Year
- CLDX N/A
- LGIH $22.47
- P/E Ratio
- CLDX N/A
- LGIH $10.81
- Revenue Growth
- CLDX 128.55
- LGIH 0.68
- 52 Week Low
- CLDX $22.93
- LGIH $84.00
- 52 Week High
- CLDX $53.18
- LGIH $136.36
- Technical
- Relative Strength Index (RSI)
- CLDX 47.58
- LGIH 31.76
- Support Level
- CLDX $24.14
- LGIH $89.01
- Resistance Level
- CLDX $25.83
- LGIH $101.52
- Average True Range (ATR)
- CLDX 1.23
- LGIH 3.11
- MACD
- CLDX 0.02
- LGIH -1.06
- Stochastic Oscillator
- CLDX 48.41
- LGIH 12.02
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140,CDX-0159/Anti-KIT Program, and CDX-527.
About LGIH LGI Homes Inc.
LGI Homes Inc is engaged in the design, construction, and sale of new homes in markets. The company current product offerings include entry-level homes, including both detached homes and townhomes, and move-up homes sold, which are sold under LGI Homes brand, and luxury series homes, which are sold under the Terrata Homes brand. It offers a set number of floor plans in each community with features that include upgrades, such as granite countertops, appliances, and ceramic tile flooring. They have seven operating segments ( Central, Midwest, Southeast, Mid-Atlantic, Northwest, West and Florida divisions) that it aggregates into five qualifying reportable segment. Majority of the revenue is generated from Central division segment.